Almitas Capital’s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share JEMD Stock Holding History

Almitas Capital’s Portfolio JEMD Stock Details JEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-223,482	Closed	-$1.44M	–	152
2022 Q3	$1.44M	Buy	223,482 +188,020	+530%	+$1.23M	1.07%	28
2022 Q2	$237K	Buy	35,462 +13,697	+63%	+$94.6K	0.12%	63
2022 Q1	$152K	Buy	+21,765	New	+$158K	0.09%	60
2019 Q1	–	Sell	-176,199	Closed	-$1.34M	–	86
2018 Q4	$1.34M	Buy	+176,199	New	+$1.36M	0.91%	34

Almitas Capital's JEMD Position: Q4 2022 in Review

Almitas Capital sold out of Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share (JEMD) in Q4 2022, closing a stake of 223,482 shares — an estimated $1.44M sold.

Almitas Capital first reported a position in JEMD in Q4 2018 and held it in 4 quarters. The position peaked at $1.44M in Q3 2022. 0 funds tracked by Wall St. Rank hold JEMD as of Q4 2022.

Almitas Capital reported no remaining Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position as of Q4 2022 after selling out during the quarter.
Almitas Capital sold 223,482 Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share shares in Q4 2022, an estimated $1.44M.
Almitas Capital first reported a position in Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q4 2018 and held it in 4 quarters.
Almitas Capital's Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position peaked at $1.44M in Q3 2022.
0 funds tracked by Wall St. Rank held Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share as of Q4 2022.

Based on Almitas Capital's 13F filing for Q4 2022, filed 14 Feb 2023.